DJIA 16,677.90 216.58 1.32%
NASDAQ 4,452.79 69.95 1.60%
S&P 500 1,950.82 23.71 1.23%
market minute promo

3.42 0.11 (3.32%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CYCC $3.42 3.32%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.39
Previous Close $3.31
Daily Range $3.30 - $3.45
52-Week Range $2.68 - $5.25
Market Cap $77.6M
P/E Ratio -3.68
Dividend (Yield) $0.00 (0.0%)
Volume 187,893
Average Daily Volume 111,433
Current FY EPS -$1.06

Sector

Healthcare

Industry

Drugs

CYCLACEL PHARMACEUTICALS, INC. (CYCC) Description

A development-stage biopharmaceutical company dedicated to the discovery, development and eventual commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Website: http://www.cyclacel.com/

News & Commentary

Cyclacel Announces New Stock Issue

The pharmaceutical company hopes to reap gross proceeds of around $20 million from the offering.

Cyclacel Provides SEAMLESS Study Update on Sapacitabine - Analyst Blog

Exact Sciences (EXAS) Looks Strong: Stock Surges 35.8% - Tale of the Tape

Sector Update: Health-Care Shares Flat Pre-Market

Sector Update: Health Care

Zacks Rank #1 Additions for Wednesday - Tale of the Tape

Zacks Rank #1 Additions for Monday - Tale of the Tape

Cyclacel Pharmaceuticals (CYCC) in Focus: Stock Jumps 5.4% - Tale of the Tape

Integra Freedom Wrist's Commercial Availability Falls Flat - Analyst Blog

Integra Freedom Wrist's Commercial Availability Falls Flat - Analyst Blog

Cyclacel Pharma Reports CYC065 CDK Inhibitor Shows Terapeutic Potential in Acute Leukemias with MLL

Cyclacel Pharma Reports CYC065 CDK Inhibitor Shows Terapeutic Potential in Acute Leukemias with MLL Rearrangements

With Cyclacel, The Waiting Is The Hardest Part

See More CYCC News...

CYCC's Top Competitors

CYCC $3.42 (3.32%)
Current stock: CYCC
AMGN $147.25 (2.51%)
Current stock: AMGN
BIIB $316.06 (2.26%)
Current stock: BIIB
CELG $100.40 (5.95%)
Current stock: CELG